TALENs Facilitate Single-step Seamless SDF Correction of F508del CFTR in Airway Epithelial Submucosal Gland Cell-derived CF-iPSCs
Cystic fibrosis (CF) is a recessive inherited disease associated with multiorgan damage that compromises epithelial and inflammatory cell function. Induced pluripotent stem cells (iPSCs) have significantly advanced the potential of developing a personalized cell-based therapy for diseases like CF by...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_aa7f6c58c90142c2a88dd3a6fd6f2d5f | ||
042 | |a dc | ||
100 | 1 | 0 | |a Shingo Suzuki |e author |
700 | 1 | 0 | |a R Geoffrey Sargent |e author |
700 | 1 | 0 | |a Beate Illek |e author |
700 | 1 | 0 | |a Horst Fischer |e author |
700 | 1 | 0 | |a Alaleh Esmaeili-Shandiz |e author |
700 | 1 | 0 | |a Michael J Yezzi |e author |
700 | 1 | 0 | |a Albert Lee |e author |
700 | 1 | 0 | |a Yanu Yang |e author |
700 | 1 | 0 | |a Soya Kim |e author |
700 | 1 | 0 | |a Peter Renz |e author |
700 | 1 | 0 | |a Zhongxia Qi |e author |
700 | 1 | 0 | |a Jingwei Yu |e author |
700 | 1 | 0 | |a Marcus O Muench |e author |
700 | 1 | 0 | |a Ashley I Beyer |e author |
700 | 1 | 0 | |a Alessander O Guimarães |e author |
700 | 1 | 0 | |a Lin Ye |e author |
700 | 1 | 0 | |a Judy Chang |e author |
700 | 1 | 0 | |a Eli J Fine |e author |
700 | 1 | 0 | |a Thomas J Cradick |e author |
700 | 1 | 0 | |a Gang Bao |e author |
700 | 1 | 0 | |a Meghdad Rahdar |e author |
700 | 1 | 0 | |a Matthew H Porteus |e author |
700 | 1 | 0 | |a Tsuyoshi Shuto |e author |
700 | 1 | 0 | |a Hirofumi Kai |e author |
700 | 1 | 0 | |a Yuet W Kan |e author |
700 | 1 | 0 | |a Dieter C Gruenert |e author |
245 | 0 | 0 | |a TALENs Facilitate Single-step Seamless SDF Correction of F508del CFTR in Airway Epithelial Submucosal Gland Cell-derived CF-iPSCs |
260 | |b Elsevier, |c 2016-01-01T00:00:00Z. | ||
500 | |a 2162-2531 | ||
500 | |a 10.1038/mtna.2015.43 | ||
520 | |a Cystic fibrosis (CF) is a recessive inherited disease associated with multiorgan damage that compromises epithelial and inflammatory cell function. Induced pluripotent stem cells (iPSCs) have significantly advanced the potential of developing a personalized cell-based therapy for diseases like CF by generating patient-specific stem cells that can be differentiated into cells that repair tissues damaged by disease pathology. The F508del mutation in airway epithelial cell-derived CF-iPSCs was corrected with small/short DNA fragments (SDFs) and sequence-specific TALENs. An allele-specific PCR, cyclic enrichment strategy gave ≃100-fold enrichment of the corrected CF-iPSCs after six enrichment cycles that facilitated isolation of corrected clones. The seamless SDF-based gene modification strategy used to correct the CF-iPSCs resulted in pluripotent cells that, when differentiated into endoderm/airway-like epithelial cells showed wild-type (wt) airway epithelial cell cAMP-dependent Cl ion transport or showed the appropriate cell-type characteristics when differentiated along mesoderm/hematopoietic inflammatory cell lineage pathways. | ||
546 | |a EN | ||
690 | |a cystic fibrosis iPS cells | ||
690 | |a iPSC directed differentiation | ||
690 | |a polynucleotide gene targeting/genome editing | ||
690 | |a sequence-specific chimeric endonucleases | ||
690 | |a SFHR | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Molecular Therapy: Nucleic Acids, Vol 5, Iss C (2016) | |
787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2162253116300099 | |
787 | 0 | |n https://doaj.org/toc/2162-2531 | |
856 | 4 | 1 | |u https://doaj.org/article/aa7f6c58c90142c2a88dd3a6fd6f2d5f |z Connect to this object online. |